AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DORAMECTIN

10 registrations across 5 African markets— 9 active

Markets with DORAMECTIN

Recent registrations

Brand / ProductMarketHolderStatusExpires
Dectomax 20 ml
Solution for Injection
🇿🇲ZambiaZOETIS BELGIUM SAactiveDec 2030
Dectomax solution for injection 500ml
Injection
🇿🇲ZambiaZOETIS BELGIUM SAactiveDec 2030
DUROMECT
SOLUTION; INJECTION
🇿🇼ZimbabweZENEX ANIMAL HEALTHactiveJun 2030
DORAMECTIN 1% INJECTION🇬🇭GhanaactiveMar 2030
DORAMECTIN 1% INJECTION🇬🇭GhanaactiveMar 2030
DECTOMAX
SOLUTION; INJECTION
🇿🇼ZimbabweZOETIS BELGIUM SAactiveDec 2027
DECTOMAX® INJECTABLE SOLUTION
PARENTERAL ORDINARY VIALS
🇺🇬UgandaZOETIS BELGIUM SAexpiredFeb 2024
Baromectin
Solution for Intramuscular Injection
🇹🇿TanzaniaBAJUTA INTERNATIONAL (T) LTDactive
DOSAMECTIN
Solution for injection
🇹🇿TanzaniaSAMORIN INTERNATIONAL (AFRICA) LIMITEDactive
DECTOMAX
Solution for injection
🇹🇿TanzaniaZoetis Belgium SAactive

DORAMECTIN in Africa — Regulatory Overview

DORAMECTIN is registered across 5 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Ghana, Zambia, Zimbabwe and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 9 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.